Robyn O'Brien joined the Liu Idea Lab of Innovation and Entrepreneurship to discuss how she's found success in advocating for change with her latest startup. Photo via robynobrien.com

Robyn O'Brien, co-founder of rePlant Capital and Rice adjunct professor, joined the Liu Idea Lab for Innovation and Entrepreneurship for the first virtual Ladies who LaUNCH. RePlant Capital is working with food industry players to invest in resilient and sustainable agricultural practices. She continues working toward her goal to "make clean and safe food affordable and accessible to anyone who wants it."

After receiving an MBA from Rice, O'Brien found herself thrust into the world of food as a financial analyst. Years later when her one-year old child had a severe allergic reaction, Robyn's previous work experience in the food industry suddenly became much more personal. She dug into the data and unearthed injustice hidden in the US food industry, resulting in her book, The Unhealthy Truth. She brought to light some shocking realities about the rise in food related allergies in the US and the double standards of food quality in the US versus other international markets. Companies were selling one product in Europe with wholesome ingredients, while "the same" product in the US was made of artificial ingredients and chemicals.

As a rebel-rousing public figure, Robyn has received her fair share of push back, but she has come out of the storm more resilient and compassionate because of it. Over the course of her hour-long talk, Robyn shared some of the ways that she has been able to advocate for change, as a mom up against industry giants and those with power to silence her. A few of the strategies she has found to be fool proof are:

1. Although her story about the US food market is quite shocking, O'Brien explained that she has lead and advocated from a place of love, not fear. O'Brien reminds us, "The reason we're hurting… is because we love." Whether she's communicating with a national audience or working on a team, Robyn has found success by turning to empathy and encourages us to do the same. Even internally, when there is discourse in her team, she says, "Start with compassion."

2. Lead with data. Despite how personal the issue felt to Robyn and the anger we are justified in feeling about this issue, Robyn continually relies on the data to do the convincing as opposed to an emotional response. "Don't exaggerate… data will tell it's own story." She encourages us to do our homework, know our facts, and walk into meetings confidently.

3. You have to exercise courage daily. ""Courage is a muscle. The more you use it, the stronger it gets." And when your internal meter senses something is misaligned, listen to it. There is room for change in departments and large organizations and it takes courage to address these issues. But it also takes courage to recognize the "gut check" and acknowledge when the misalignment is too great, and to walk away.

O'Brien is a great example of sticking to your guns, even when you're up against a global industry. Now, I leave you with the challenge of taking smaller steps – plant seeds of change where you are and advocate for individuals in need.

------

This article originally appeared on Liu Idea Lab for Innovation & Entrepreneurship's blog.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”